Xizang Weixinkang Pharmaceutical: Subsidiary Compound Amino Acid Injection Obtains Drug Registration Certificate
On April 27th, Xizang Weixinkang Pharmaceutical announced that its subsidiary, Inner Mongolia Baiyi Pharmaceutical Co., Ltd., has obtained the Drug Registration Certificate for Compound Amino Acid Injection issued by the National Medical Products Administration. Compound Amino Acid Injection is an adult amino acid supplement used for patients with acute and chronic renal insufficiency who experience hypoproteinemia, malnutrition, and amino acid supplementation before and after surgery